The conference provides a forum for the presentation and discussion of latest developments and cutting – edge research in the field of Clinical Microbiology and Pathology that applies in the diagnosis, treatment and prevention of diseases.
Microbial Pathology-2018 will feature a large number of stimulating presentations throughout the two day event, including keynote presentations, oral and poster presentations. Delegates will hear about the latest research or innovation in education in a myriad of different contexts, and will have the opportunity to actively participate in an interactive program.
Best student papers will be judged and awarded during the conference. Young researchers are invited to join the conference on a reduced conference fee.
Microbial Pathology-2018 encourages the sharing of research and innovation across the following sub-themes as well as directly related to the overall conference theme – To encompass emerging trends in Clinical Microbiology and Pathology.
Allied Academies conferences invites all
the participants to attend “Annual Summit on Clinical
Microbiology and Pathology” from October
15-16, 2018 in Toronto, Canada. Our
conference is the premier gathering of the specialized
and experts in field of Microbiology, Infection Control and Prevention &
Pathology from all over the world which includes knowledge sharing,
research updates and presentations of keynote, Oral, Poster, Workshops and
Exhibitions. Allied Academies arrange a brilliant platform for business
delegates by arranging workshops and exhibitions for their products this
scientific meet help business expansion and form new contacts.
1. Emerging Microbes & Infection
The microbial world is complex, dynamic, and constantly emerging. Infection causing organisms reproduce rapidly, mutate frequently and adapt with relative ease to their new surroundings. Because of these characteristics, infectious organisms are able to alter their epidemiology, their virulence, and their susceptibility to anti-infective drugs. All forms of infectious organisms—bacteria, viruses, parasites, and prions are able to emerge or re-emerge in human populations, and it is estimated that up to 70 per cent or more of all emerging infections have a source in animals.
2. Microbial Genomics & Genome Sequencing
The molecular mechanisms of infectious disease and identify potential therapeutic and diagnostic targets by exploiting next-generation genomic data. It focuses on the comparative analysis of genomes obtained from local clinical isolates of important human pathogens such as Escherichia coli, Pseudomonas aeruginosa, Staphylococci, Streptococci, Legionella pneumophila and Acinetobacter baumannii and many other microorganisms.
3. Microbial Biofilms
Biofilms are the default mode-of-life for many bacterial species. The variety of microniches provided by the biofilm also promotes a huge diversity of microbial life and metabolic potential. These complex and highly structured communities help to maintain the health of soils and waters. Current applications of biofilms include the degradation of toxic substances in soil and water, the commercial production of chemicals, and the generation of electricity. Biofilm-based infections causes harm to millions of humans annually. In addition, biofilms can affect the quality and yield of crops and cause biofouling and microbial-induced corrosion.
4. Infection Control & Prevention
Infection control is the discipline concerned with preventing nosocomial or healthcare-associated infection, a practical sub-discipline of epidemiology. It is an essential, though often under recognized and under supported, part of the infrastructure of health care. Infection control and hospital epidemiology are akin to public health practice, practiced within the confines of a particular health-care delivery system rather than directed at society as a whole. Anti-infective agents include antibiotics, antibacterials, antifungals, antivirals and antiprotozoals.
Immunology is the study of the immune system and is a very important branch of the medical and biological sciences, that deals with the response of an organism to antigenic challenge and its recognition of what is self and what is not. It deals with the defence mechanisms including all physical, chemical and biological properties of the organism that help it to combat its susceptibility to foreign organisms, material, etc.
6. Clinical &
Clinical pathology covers a wide range of laboratory functions and is concerned with the diagnosis, treatment, and prevention of disease. Clinical pathology also involves maintenance of information systems, research, and quality control. Infectious diseases pathology involves the Clinical pathology of the diagnosis of disease through the analysis of bodily fluids viz., blood and urine, or tissues, through the application of clinical microbiology, haematology and molecular pathology. It consists of Hematopathology Immunopathology and Radiation Pathology. Includes the study of blood cells, lymph nodes, bone marrow, immune system and other bodily functions.
7. Multiple Organ Pathology
The pathological observation of the multiple organ ( like skin, renal, GI etc) and related components, are included in the field of Multiple organ pathology. Dermatopathology one of the most important speciality in the anatomic pathology focuses on the skin and the diseases, that affect the skin and then proceeds attacking other organs. Gynecologic pathology deals with the study, manifestation and diagnosis of the diseases in the female genital tract and breasts .The gastrointestinal (GI) pathology determines quality diagnostic histopathology on gastrointestinal endoscopic biopsies and resections of the gastrointestinal and pancreatico -biliary systems. Pulmonary pathology deals with the neoplastic and non-neoplastic diseases.While Renal pathology is mostly dealt with in during transplants and other kidney diseases. The nervous system and related components, for autopsy or biopsies are included in the field of Neuropathology.
8. Surgical Pathology
Surgical pathology is the crux of pathological examination for most pathologists, as it involves the microscopic examination of surgical specimens and biopsy samples through macroscopic, or histologic or microscopic examination or through the immune histochemical tests of the samples.
9. Forensic Pathology & Digital Pathology
The crux of Forensic pathology is not only on autopsies of the corpse, but it also helps in finding of the clues at the crime scenes and is useful in criminal examinations. Toxicology and Pharmacology are 2 of the most essential units in Forensic pathology. Digital pathology is a recent addition to the field of pathology, wherein the diagnosis of the infections and also the analysis of the specimen is done digitally through pre-fed data to the systems.
10. Transfusion Medicine
Transfusion medicine is the branch of medicine that is concerned with transfusion of blood and blood components. It encompasses issues of blood donation, immunohematology and other laboratory testing, transfusion practices, therapeutic apheresis, stem cell collections, cellular therapy, and coagulation. Laboratory management and understanding of state and federal regulations related to blood products are also a large part of the field.
Microbial Pathology 2018 is an opportunity to focus and analyse recent innovations and challenges in the field of Clinical Microbiology, Microbial Genomics and Pathology. Thus contributing both academicians and business partners to grow and spread their research and product respectively. Microbial Pathology 2018 welcome attendees, presenters and exhibitors from all over the world.
Global Market Research Report:
The Global Clinical Microbiology Market is Projected to reach USD 5.77 billion by 2021 From USD 3.39 billion in 2017, at a CAGR of 11.5%, during 2017 to 2021. Market growth can be attributed to factors such as the technological advancements; rising incidence of infectious diseases and growing outbreak of epidemics; growing healthcare expenditure across the world; and increasing funding, research grants, and public-private investments in the field of life science research.
The global molecular diagnostics market was valued at nearly $10.9 billion in 2017. The market is projected to grow at a compound annual growth rate (CAGR) of 14.3% from 2017 through 2022 to reach $11.6 billion by 2018 and $23.8 billion by 2022.
The global digital pathology market size was valued at USD 351.1 million in 2017 and is expected to witness a CAGR of 12.1% during the forecast period. Digital Pathology Market is growing rapidly and is expected to grow at the CAGR of 11.9% by the end of 2022. Increased focus on improving workflow efficiency and faster diagnostic tools for chronic diseases, such as cancer, has been a key factor for surge in demand for digital pathology.
The global surgical pathology market is projected to reach USD 915.6 Million by 2021 from USD 610.1 Million in 2017 growing at a CAGR of 12.5% during the forecast period.
In 2017, Canada and Europe markets are expected to hold the largest
share of the global market for clinical microbiology product. However, emerging
regions such as Asia-Pacific (including Japan, China, and India) are expected
to become the new revenue-generating pockets in the market in the next five
years, due to growing number of hospitals and clinical diagnostic laboratories
in India and China; expanding research capabilities for the development of
innovative and affordable clinical microbiology testing procedures
across India, China, and Japan; and rising incidences of infectious diseases.
Some major Pathology laboratory, Healthcare department, Hospitals, Diagnostic centres associated with clinical microbiology and pathology research.
Companies Market Analysis Report:
pharmaceutical sector is one of the most innovative industries in Canada.
It is composed of
companies developing and manufacturing innovative medicines and generic pharmaceuticals, as well as over–the-counter drug products. The sector is made up of a number of sub-sectors that service different market segments. These include brand-name pharmaceutical companies, generic drug firms, biopharmaceutical small and medium sized enterprises (biopharmaceutical SMEs), and contract service providers (CSP).
Annual domestic pharmaceutical manufacturing production is valued at $10.7 billion in 2017 with a compound annual growth rate of 1.0% since a decade.
& Johnson Novartis
Astra Zeneca Roche
The global market for organ and tissue transplantation products and devices reached $75.9 billion in 2017. This market is estimated to grow at a compound annual growth rate (CAGR) of 7.1% to reach nearly $93.6 billion by 2022.
Cryo Life Inc.
Life Cell Corporation
The Global Forensic Technology market was valued at $9,759 million in 2017, and is estimated to reach $22,905 million by 2023, growing at a CAGR of 13.4% during the study period.
The global Clinical Microbiology testing technologies market is expected to be worth US$3.4 billion by the end of 2024 from US$2.4 billion in 2017. During the forecast years of 2017 and 2024, the global market is expected to expand at a CAGR of 5.4% due to the increasing demand for automation in the field of Clinical Microbiology.
Beckman Coulter, Inc
These players are focused on new product development, diversification, market development, penetration to retain their dominance over the forecast period
Scope of the Report:
- Market study assessments for the regional and country level segments.
-Market study analysis of the top industry players.
-To analyse the market based on various factors-price analysis, supply chain analysis, porters five force analysis etc.
-The global digital pathology market has been evaluated as rapidly growing market and expected that the market will reach high growth figures.
-To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- Americas, Europe, Asia-Pacific, and Middle East & Africa.
-There has been huge demand for digital pathology in the pharmaceutical and biotechnology companies as well as reference laboratories.
Top Societies and Associations Around the World:
Canadian Association for Clinical Microbiology and Infectious Diseases
European Society of Pathology
American Society for Microbiology
Clinical Immunology Society
Association For Molecular Pathology
Federation of European Microbiological Society
The Swiss Society for Microbiology
Southeastern Association for Clinical Microbiology (SEACM)
University of Oxford
Imperial College London
University of Tokyo
University of Cambridge
University of Glasgow
University of Manchester
University of Nottingham
Universities of USA and Canada
University of California, Los Angeles
University of Toronto
Directors, Board Members, Presidents, Vice Presidents, Deans and Head of the Department
Directors of Associations and Societies
Researchers, Scientists, Faculties, Students
Clinical Microbiology and Pathology Associations and Societies
Pharmaceutical Companies and Industries
Medical Devices Manufacturing Companies
Drug Manufacturing Companies and Industries
Laboratory Technicians and Diagnostic Companies
Business Entrepreneurs and Industrialists